BTEC.L vs. GXLV.L
BTEC.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) and GXLV.L (SPDR S&P US Health Care Select Sector UCITS ETF) are both Health & Biotech Equities funds - BTEC.L tracks the NASDAQ Biotechnology NET Index while GXLV.L tracks the MSCI World/Health Care NR USD. Both are passively managed. Over the past 5 years, BTEC.L returned 5.94%/yr vs -0.47%/yr for GXLV.L. At a 0.48 correlation, their price movements are largely independent. BTEC.L charges 0.35%/yr vs 0.15%/yr for GXLV.L.
Performance
BTEC.L vs. GXLV.L - Performance Comparison
Loading charts...
Different Trading Currencies
BTEC.L is traded in USD, while GXLV.L is traded in GBP. To make them comparable, the GXLV.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, BTEC.L achieves a 15.64% return, which is significantly higher than GXLV.L's 4.65% return.
BTEC.L
- 1D
- 0.42%
- 1M
- 8.47%
- 6M
- 14.00%
- YTD
- 15.64%
- 1Y
- 47.62%
- 3Y*
- 17.00%
- 5Y*
- 5.94%
- 10Y*
- —
GXLV.L
- 1D
- 0.00%
- 1M
- 7.41%
- 6M
- 4.12%
- YTD
- 4.65%
- 1Y
- 23.02%
- 3Y*
- 8.44%
- 5Y*
- -0.47%
- 10Y*
- 6.72%
BTEC.L vs. GXLV.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) | 15.64% | 32.96% | -2.04% | 6.22% | -11.92% | -0.49% | 27.40% | 25.57% | -11.22% | -3.31% |
GXLV.L SPDR S&P US Health Care Select Sector UCITS ETF | 4.65% | 15.16% | 2.00% | 1.16% | -27.54% | 24.44% | 16.42% | 25.10% | 0.01% | 1.79% |
Correlation
The correlation between BTEC.L and GXLV.L is 0.61, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.61 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.57 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.56 |
Correlation (All Time) Calculated using the full available price history since Oct 19, 2017 | 0.48 |
The correlation between BTEC.L and GXLV.L shifts across timeframes, from 0.48 (all time) to 0.61 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BTEC.L vs. GXLV.L — Risk / Return Rank
BTEC.L
GXLV.L
BTEC.L vs. GXLV.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) and SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BTEC.L | GXLV.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.81 | ||
| Sortino ratioReturn per unit of downside risk | +0.89 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.26 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 5.97 | 2.21 | +3.76 |
| Martin ratioReturn relative to average drawdown | 18.32 | 5.43 | +12.89 |
Loading charts...
Drawdowns
BTEC.L vs. GXLV.L - Drawdown Comparison
The maximum BTEC.L drawdown since its inception was -38.42%, roughly equal to the maximum GXLV.L drawdown of -37.17%. Use the drawdown chart below to compare losses from any high point for BTEC.L and GXLV.L.
Loading charts...
Drawdown Indicators
| BTEC.L | GXLV.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.42% | -37.17% | -1.25% |
Max Drawdown (1Y)Largest decline over 1 year | -7.94% | -10.45% | +2.51% |
Max Drawdown (3Y)Largest decline over 3 years | -26.74% | -17.58% | -9.16% |
Max Drawdown (5Y)Largest decline over 5 years | -38.42% | -37.17% | -1.25% |
Max Drawdown (10Y)Largest decline over 10 years | — | -37.17% | — |
Current DrawdownCurrent decline from peak | -3.51% | -10.04% | +6.53% |
Average DrawdownAverage peak-to-trough decline | -13.22% | -15.56% | +2.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.59% | 4.25% | -1.66% |
Volatility
BTEC.L vs. GXLV.L - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) and SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L) have volatilities of 5.44% and 5.37%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BTEC.L | GXLV.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.44% | 5.37% | +0.07% |
Volatility (6M)Calculated over the trailing 6-month period | 15.67% | 11.46% | +4.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.42% | 15.26% | +5.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.38% | 18.35% | +3.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.37% | 19.85% | +2.52% |
BTEC.L vs. GXLV.L - Expense Ratio Comparison
BTEC.L has a 0.35% expense ratio, which is higher than GXLV.L's 0.15% expense ratio.
Dividends
BTEC.L vs. GXLV.L - Dividend Comparison
Neither BTEC.L nor GXLV.L has paid dividends to shareholders.
Frequently Asked Questions
BTEC.L and GXLV.L have a correlation of 0.61, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, GXLV.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GXLV.L is cheaper with a 0.15% expense ratio, compared with 0.35% for BTEC.L.
BTEC.L tracks NASDAQ Biotechnology NET Index, while GXLV.L tracks MSCI World/Health Care NR USD. They also come from different issuers: iShares and State Street. Their fees differ too: 0.35% for BTEC.L and 0.15% for GXLV.L.
Find the right allocation for BTEC.L and GXLV.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer